Found: 3
Select item for more details and to access through your institution.
Commercial anti‐CD19 CAR T cell therapy for patients with relapsed/refractory aggressive B cell lymphoma in a European center.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 11, p. 1324, doi. 10.1002/ajh.25951
- By:
- Publication type:
- Article
Virological outcome at week 48 of three recommended first-line regimens using ultrasensitive viral load and plasma drug assay.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Virological outcome at week 48 of three recommended first-line regimens using ultrasensitive viral load and plasma drug assay.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2014, v. 69, n. 10, p. 2819, doi. 10.1093/jac/dku211
- By:
- Publication type:
- Article